Clinical, Meibographic and Interferometric Evaluation of Phlyctenular Keratitis in Children - MEIBO-ROSACEE
NCT03479853 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102
Last updated 2020-05-13
Summary
The aim of this study is to describe the clinical, meibographic and interferometric manifestations of phlyctenular keratitis in children.
Conditions
- Ocular Rosacea
- Keratoconjunctivitis
- Meibomian Gland Dysfunction
Interventions
- PROCEDURE
-
Ophthalmologic examination and meibographic and interferometric evaluation (Lipiview device)
Classic ophthalmologic examination with visual acuity measurement and slit lamp examination of both eyes and eyelids. Then, meibographic and interferometric evaluation of his two inferior eyelids with the Lipiview device.
Sponsors & Collaborators
-
Fondation Ophtalmologique Adolphe de Rothschild
lead NETWORK
Principal Investigators
-
Serge DOAN, MD · Fondation Ophtalmologique A. de Rothschild
Eligibility
- Min Age
- 2 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-02
- Primary Completion
- 2020-03-12
- Completion
- 2020-05-11
Countries
- France
Study Locations
More Related Trials
-
Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety
NCT02953938 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy
NCT00679445 ·Status: COMPLETED ·Phase: PHASE2
-
Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)
NCT01006538 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X)
NCT02375685 ·Status: TERMINATED ·Phase: PHASE3
-
Phase 2 Study of MM-093 to Treat Patients With Uveitis
NCT00444743 ·Status: COMPLETED ·Phase: PHASE2
-
Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema
NCT02055911 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma
NCT01370135 ·Status: COMPLETED ·Phase: NA
-
The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma
NCT00943982 ·Status: COMPLETED ·Phase: PHASE1
-
Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation
NCT00457145 ·Status: COMPLETED ·Phase: PHASE1
-
Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa
NCT02386774 ·Status: COMPLETED ·Phase: NA
-
A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy
NCT00809419 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis
NCT02879084 ·Status: COMPLETED
-
Treatment of Failing Blebs With Ranibizumab
NCT00570726 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye
NCT01531842 ·Status: UNKNOWN ·Phase: NA
-
Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppressive Therapy
NCT06821971 ·Status: ACTIVE_NOT_RECRUITING
-
Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients
NCT02396316 ·Status: COMPLETED ·Phase: PHASE3
-
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
NCT02375971 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
NCT01747538 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration
NCT00813891 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration
NCT01780935 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel
NCT01949324 ·Status: COMPLETED ·Phase: PHASE2
-
Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)
NCT01327911 ·Status: COMPLETED ·Phase: PHASE1
-
Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD
NCT01269151 ·Status: COMPLETED ·Phase: NA
-
Treatment FOr Corticosteroid Dependent UveitiS
NCT06258915 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Topical Interferon Gamma for Macular Edema Secondary to Uveitis
NCT01376362 ·Status: COMPLETED ·Phase: PHASE1/PHASE2